Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice

European Journal of Pharmacology

Volumn 195, Issue 1, 1991, Pages 55-61

  Liljequist, Sture ^a   Ossowska, Krystyna ^a   Grabowska Andén, Maria ^a   Andén, Nils Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Dopamine metabolism; Hippocampus; Limbic forebrain; MK 801; NMDA receptors; NMRI mouse; Striatum

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DIZOCILPINE; DOPA; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BRAIN REGION; CATECHOLAMINE BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NUCLEUS; PRIORITY JOURNAL;

ANIMAL; BRAIN; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MICE; MOTOR ACTIVITY; RECEPTORS, N-METHYL-D-ASPARTATE; SUPPORT, NON-U.S. GOV'T;

EID: 0026101940     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(91)90381-Y     Document Type: Article

References (40)

1. Modulation of dendritic release of dopainine by N-methyl-D-aspartate receptors in rat substantia nigra
2. 2-Amino-7-phosphonoheptanoic (AP7) produces discriminative stimuli and anliconflict effects similar to diazepam
3. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-melhyl-D-aspartate receptors
4. The importance of dopaminergic neurotransmission in the hypermotilily reponse produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens
5. Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo
6. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice
7. Dramatic synergism between MK-801a nd clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice
8. Anticonvulsant activity of (+)-5-melhyl-10,11-dihydro-5H-dibenzo (a,d) cyclophepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
9. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)cyclophepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
10. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenze(a,d)cyclohepten-5,10-imine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties
11. Excitatory amino acids in the brain—focus on NMDA receptors
12. Anatomical organization of excitatory amino acid receptors and their pathways
13. Anticonvulsant of excitatory amino acid antagonists
14. Mesolimbic and mesocortical dopamine activation induced by phencyclidine contrasting pattern to striatal response
15. Determinations of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography
16. Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors
17. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
18. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain
19. The rat ventromedial thalamic nucleus and motor control: Role of N-methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission
20. Motor actions of excitatory amino acids and their antagonists within rat ventromedial thalamic nucleus
21. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
22. Glycine potentiates the NMDA-induced release of dopamine through a strychnine-insensitive site in the rat striatum
23. Simultaneous determination of dopamine, dopac, and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system
24. 3H]dopamine in the striatum of the conscious rat
25. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial prefrontal cortex of rats
26. Strain-dependent decrease in glutamate binding to the N-methyl-D-aspartic acid receptor during aging
27. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens
28. Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats
29. In vivo demonstration of the enhancement of MK-801 by L-glutamate
30. Distinct functional effects of glutamic acid and dopamine within various regions of the striatum
31. Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat
32. Role of quisqualic acid receptors in the hypermotility response produced by the injection of AMPA into the nucleus accumbens
33. Antagonism of N-methyl-D-asparlate-induced transmitter release in the rat striatum and its relationship to turning behavior
34. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release
35. NMDA receptors and ligands in the vertebrate CNS
36. The behavioural effects of MK-801: a comparison with antagonists acting non-competilively and competitively at the NMDA receptor
37. Muscle relaxant action of excitatory amino acid antagonists
38. The behavioral pharmacology of NMDA receptor antagonists
39. Excitatory amino acid antagonists: Behavioral and biochemical approaches for the development of new central nervous system therapeutic agents